Evidence map›Paper›PMID 39756348›Full record

ArticleDrug and alcohol dependence2025

Over-the-counter naloxone availability at North Carolina community pharmacies: A secret shopper study.

Delesha M Carpenter, Grace T Marley, Izabela E Annis, Paul Delamater, Kathleen L Egan

Abstract read
In one paragraph

Article in Drug and alcohol dependence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Delesha M CarpenterEshelman School of Pharmacy, Division of Pharmaceutical Outcomes and Policy, University of North Carolina at Chapel Hill, 1 University Heights, CPO 2125, Asheville, NC, USA. Electronic address: dmcarpenter@unc.edu.
Grace T MarleyEshelman School of Pharmacy, Division of Pharmaceutical Outcomes and Policy, University of North Carolina at Chapel Hill, 1 University Heights, CPO 2125, Asheville, NC, USA; South East Area Health Education Center, Wilmington, NC, USA.
Izabela E AnnisEshelman School of Pharmacy, Division of Pharmaceutical Outcomes and Policy, University of North Carolina at Chapel Hill, 1 University Heights, CPO 2125, Asheville, NC, USA.
Paul DelamaterDepartment of Geography and Environment, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Kathleen L EganDepartment of Implementation Science, Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, USA.

Funding

Creating a novel place-based measure to explain racial disparities in naloxone access to reduce opioid overdose deathsR01MD018085 · NIMHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CARPENTER, DELESHA MILLER · 2022 to 2025
$2.4M
NIMHD NIH HHS R01 MD018085
6 · The paper itself

Abstract

backgroundOver-the-counter (OTC) naloxone became available for sale at community pharmacies in September 2023. This study examines whether naloxone availability and cost are associated with pharmacy type (independent vs chain), pharmacy rurality, and their interaction.

methodsUsing a cross-sectional secret shopper study design, data were collected by phone from a stratified random sample of 600 community pharmacies in North Carolina from November 2023 to January 2024. Trained secret shoppers enacted a standardized script and documented whether the pharmacy: dispensed naloxone, sold OTC naloxone, and offered same-day pick-up. Shoppers also documented the location of OTC naloxone and out-of-pocket cost. Generalized Estimating Equations (GEEs) were used to examine whether naloxone availability and cost varied by pharmacy type (independent vs chain), rurality (urban, suburban, rural), and a rurality*type interaction.

resultsSampled pharmacies were 48.5 % urban, 11.7 % suburban, and 39.7 % rural, with 50.4 % being chain, 48.2 % independent, and 1.4 % health department pharmacies. Among the 500 pharmacies that sold naloxone, 57.4 % sold the OTC product, which was primarily stored behind-the-counter (62.5 %). Same-day pick-up was available at 82.8 % of pharmacies. In GEE models, rurality was not significant. However, independent pharmacies were significantly less likely than chain pharmacies to sell naloxone, have same-day pick-up, and store OTC naloxone on-the-shelf. Interaction terms were not significant, suggesting that the effect of pharmacy type on naloxone availability and cost did not vary by rurality.

conclusionsPharmacy type, not rurality, was consistently associated with naloxone access and out-of-pocket cost. Interventions should address barriers to naloxone access and cost at independent pharmacies.

Indexed as

Community Pharmacy ServicesHealth Services AccessibilityNaloxoneNarcotic AntagonistsNonprescription DrugsPharmaciesCross-Sectional StudiesFemaleHumansMaleNorth CarolinaRural PopulationNaloxoneNarcotic AntagonistsNonprescription DrugsNaloxoneOpiate overdosePharmacistsPharmacyRural healthTelephone audit

Identifiers

PMID39756348
PMCPMC11757043

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.